Search company, investor...
Finnadvance company logo


Founded Year



Seed VC - II | Alive

Total Raised


Last Raised

$1.3M | 8 mos ago

About Finnadvance

Finnadvance develops miniature chips for the pharmaceutical industry and for research. The chips mimic functions of a human organ and allow for more precise and expedient drug discovery. Finnadvance was founded in 2019 and is based in Oulu, Finland.

Headquarters Location

Aapistie 5A

Oulu, 90220,


+358 40 653 7049

Missing: Finnadvance's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

ESPs containing Finnadvance

The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.

Life Sciences / Biopharma Tech

These companies use patient-derived cells and tissue samples to create structures that mimic human physiology. These solutions come in two categories. Some vendors develop organoids, which are miniaturized and simplified versions of organs and tissue structures. Other vendors insert human cells into microfluidic assays in order to emulate human physiology.

Finnadvance named as Outperformer among 11 other companies, including Emulate, Hubrecht Organoid Technology, and CN Bio Innovations.

Missing: Finnadvance's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Finnadvance

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Finnadvance is included in 3 Expert Collections, including Biopharma Tech.


Biopharma Tech

838 items


Drug Discovery Tech Market Map

221 items

This CB Insights Tech Market Map highlights 220 drug discovery companies that are addressing 12 distinct technology priorities that pharmaceutical companies face.


Early-Stage Pharma Market Map

82 items

Latest Finnadvance News

Finnish biomimetic organ-on-chip platform has raised €1.2M in a seed round to revolutionize drug research and development

Apr 14, 2022

Finnish startup FinnAdvance has recently raised 1.2 million euros in a seed funding round led by Finland’s life science investor, Athensmed with the participation of Takoa Invest, a new investor. The round was also backed by the company’s existing investors Voima Ventures and Icebreaker. The capital will help the company to reach out to new […]

Finnadvance Frequently Asked Questions (FAQ)

  • When was Finnadvance founded?

    Finnadvance was founded in 2019.

  • Where is Finnadvance's headquarters?

    Finnadvance's headquarters is located at Aapistie 5A, Oulu.

  • What is Finnadvance's latest funding round?

    Finnadvance's latest funding round is Seed VC - II.

  • How much did Finnadvance raise?

    Finnadvance raised a total of $1.9M.

  • Who are the investors of Finnadvance?

    Investors of Finnadvance include Voima Ventures, Icebreaker, Athensmed, Takoa Invest and Health Incubator Helsinki.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.